Global and China Budesonide Market Research by Company, Type & Application 2013-2025

Summary
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Market Segment as follows:
By Type
Nasal spray
Inhaler
Pill&Rectal forms
By Application
Respiratory disease treatment
Nose disease treatment
Inflammatory bowel disease treatment
By Company
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.